Correlation Between Champions Oncology and Purple Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Purple Biotech, you can compare the effects of market volatilities on Champions Oncology and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Purple Biotech.

Diversification Opportunities for Champions Oncology and Purple Biotech

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Champions and Purple is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Champions Oncology i.e., Champions Oncology and Purple Biotech go up and down completely randomly.

Pair Corralation between Champions Oncology and Purple Biotech

Given the investment horizon of 90 days Champions Oncology is expected to generate 1.23 times more return on investment than Purple Biotech. However, Champions Oncology is 1.23 times more volatile than Purple Biotech. It trades about 0.32 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.04 per unit of risk. If you would invest  787.00  in Champions Oncology on October 25, 2024 and sell it today you would earn a total of  334.00  from holding Champions Oncology or generate 42.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Champions Oncology  vs.  Purple Biotech

 Performance 
       Timeline  
Champions Oncology 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.
Purple Biotech 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Purple Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Purple Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point.

Champions Oncology and Purple Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Champions Oncology and Purple Biotech

The main advantage of trading using opposite Champions Oncology and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.
The idea behind Champions Oncology and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal